Roche Holding AG (XSWX:ROP) Net Loan


XSWX:ROP Roche Holding AG XSWX:ROP
75 GF Score
Price CHF334.90
GF Value CHF264.64
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Net Loan?

Net Loan only applies to banks and insurance companies.

XSWX:ROP
75GF Score
Roche Holding AG XSWX:ROP
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF334.90 is trading 26.5% above its estimated GF Value™ of CHF264.64. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:ROP:

  • Net Loan:
  • GF Value™: CHF264.64 vs. price of CHF334.90 (26.5% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
75GF Score

Get the complete analysis for XSWX:ROP

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF334.90
Price
CHF264.64
GF Value